The Bioreactor system manufacturer Applikon Biotechnology B.V. (Schiedam, The Netherlands) has today announced a Management Buy Out of the company in a deal designed to enable the business to continue to build on its existing growth as a major supplier to the global biotechnology and pharmaceutical market. The Applikon Biotechnology directors heading the buy-out are managing director Arthur Oudshoorn, sales and marketing director Erik Kakes and Manager Engineering and Product Development Jaap Oostra. A delighted Arthur Oudshoorn said “This is fantastic news, not just for the Applikon Biotechnology’s team, but for all our partners and customers. By maintaining our passion for designing, marketing and building bioreactor systems, our commitment to quality and our thirst for innovation, we are uniquely positioned as a privately owned company to further develop our position as a key player in the global pharmaceutical and biotechnology markets.” Jaap Oostra commented “I am excited about this deal as we keep the critical mass required to develop next generation products for the rapidly changing biotechnology and pharmaceutical market. With a lot of new products in the pipeline both in single-use and re-usable technology, we have a clear outlook for exciting new products to enter the market very soon.” Erik Kakes said “I couldn’t be happier. We’ve all worked really hard for this and I’m looking forward to realizing our full potential in the future. In the meantime we’ll be concentrating on successfully completing what has been another year of record growth for Applikon Biotechnology.” Applikon Biotechnology B.V. will remain based at its locations in Schiedam in The Netherlands, Tewkesbury in the United Kingdom and Foster City (CA) and Dover (NJ) in the USA and will retain all its current employees. The on-going expansion of our network of distributors will provide a strong basis for strategic growth globally. Applikon Biotechnology is expected to make further announcements about its strategy for future growth at the Biotechnica exhibition (Hannover, Germany, 7-9 October 2008, Hall 9, booth G40), where the company will be further expanding its single-use bioreactor ranges and control system capabilities with a number of new products.